Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

BACKGROUND: Infection/reactivation of cytomegalovirus is a major cause of morbidity and mortality in immunocompromised transplant patients. It has already been observed in kidney and liver transplantation patients that cytomegalovirus disease is accompanied by significant increases in circulating CD...

Full description

Bibliographic Details
Main Authors: Vânia Abadia Soares Lino, Silvana Maria Eloi Santos, Henrique Neves da Silva Bittencourt, Maria Luiza Silva, Tiago Spizziri, Raquel Bretas, Suzane Pretti Figueiredo Neves
Format: Article
Language:English
Published: Elsevier 2011-01-01
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000400010
_version_ 1818032219036319744
author Vânia Abadia Soares Lino
Silvana Maria Eloi Santos
Henrique Neves da Silva Bittencourt
Maria Luiza Silva
Tiago Spizziri
Raquel Bretas
Suzane Pretti Figueiredo Neves
author_facet Vânia Abadia Soares Lino
Silvana Maria Eloi Santos
Henrique Neves da Silva Bittencourt
Maria Luiza Silva
Tiago Spizziri
Raquel Bretas
Suzane Pretti Figueiredo Neves
author_sort Vânia Abadia Soares Lino
collection DOAJ
description BACKGROUND: Infection/reactivation of cytomegalovirus is a major cause of morbidity and mortality in immunocompromised transplant patients. It has already been observed in kidney and liver transplantation patients that cytomegalovirus disease is accompanied by significant increases in circulating CD8+CD38+ T lymphocytes. There are no reports that study CD8+CD38+ T lymphocytes to monitor/diagnose cytomegalovirus disease in hematopoietic stem cell transplantation patients. OBJECTIVE: The aim of this study was to evaluate some cellular activation markers on circulating mononuclear cells (CD38 and HLA-DR) in patients submitted to hematopoietic stem cell transplantation and to establish any correlation with cytomegalovirus disease as diagnosed by antigenemia. METHODS: Blood samples of 15 transplant patients were analyzed by flow cytometry using anti-CD3, anti-CD4, anti-CD8, anti-CD38, CD16, CD56 and anti-HLA-DR monoclonal antibodies and the results were evaluated in respect to cytomegalovirus antigenemia measured by indirect immunofluorescence. Minitab for Windows was used for statistical analysis and a p-value < 0.05 was considered significant. RESULTS: Patients with positive antigenemia did not show any significant increase in the percentages of cells expressing the CD38 or HLADR activation markers when compared to patients with negative antigenemia. On the contrary, all patients showed high percentages of these cells independent of the presence of cytomegalovirus disease. CONCLUSIONS: This study suggests that the investigation of these lymphocyte sub-populations in patients submitted to hematopoietic stem cell transplantation does not seem to contribute to the early identification of cytomegalovirus disease.
first_indexed 2024-12-10T06:03:53Z
format Article
id doaj.art-44565e82118f4308b200245e8ab2bb7d
institution Directory Open Access Journal
issn 1516-8484
1806-0870
language English
last_indexed 2024-12-10T06:03:53Z
publishDate 2011-01-01
publisher Elsevier
record_format Article
series Revista Brasileira de Hematologia e Hemoterapia
spelling doaj.art-44565e82118f4308b200245e8ab2bb7d2022-12-22T01:59:44ZengElsevierRevista Brasileira de Hematologia e Hemoterapia1516-84841806-08702011-01-0133426827310.5581/1516-8484.20110075Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationVânia Abadia Soares LinoSilvana Maria Eloi SantosHenrique Neves da Silva BittencourtMaria Luiza SilvaTiago SpizziriRaquel BretasSuzane Pretti Figueiredo NevesBACKGROUND: Infection/reactivation of cytomegalovirus is a major cause of morbidity and mortality in immunocompromised transplant patients. It has already been observed in kidney and liver transplantation patients that cytomegalovirus disease is accompanied by significant increases in circulating CD8+CD38+ T lymphocytes. There are no reports that study CD8+CD38+ T lymphocytes to monitor/diagnose cytomegalovirus disease in hematopoietic stem cell transplantation patients. OBJECTIVE: The aim of this study was to evaluate some cellular activation markers on circulating mononuclear cells (CD38 and HLA-DR) in patients submitted to hematopoietic stem cell transplantation and to establish any correlation with cytomegalovirus disease as diagnosed by antigenemia. METHODS: Blood samples of 15 transplant patients were analyzed by flow cytometry using anti-CD3, anti-CD4, anti-CD8, anti-CD38, CD16, CD56 and anti-HLA-DR monoclonal antibodies and the results were evaluated in respect to cytomegalovirus antigenemia measured by indirect immunofluorescence. Minitab for Windows was used for statistical analysis and a p-value < 0.05 was considered significant. RESULTS: Patients with positive antigenemia did not show any significant increase in the percentages of cells expressing the CD38 or HLADR activation markers when compared to patients with negative antigenemia. On the contrary, all patients showed high percentages of these cells independent of the presence of cytomegalovirus disease. CONCLUSIONS: This study suggests that the investigation of these lymphocyte sub-populations in patients submitted to hematopoietic stem cell transplantation does not seem to contribute to the early identification of cytomegalovirus disease.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000400010Hematopoietic stem cell transplantationCytomegalovirusFlow cytometryAntigenemia, CD38
spellingShingle Vânia Abadia Soares Lino
Silvana Maria Eloi Santos
Henrique Neves da Silva Bittencourt
Maria Luiza Silva
Tiago Spizziri
Raquel Bretas
Suzane Pretti Figueiredo Neves
Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
Revista Brasileira de Hematologia e Hemoterapia
Hematopoietic stem cell transplantation
Cytomegalovirus
Flow cytometry
Antigenemia, CD38
title Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
title_full Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
title_fullStr Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
title_full_unstemmed Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
title_short Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
title_sort quantification of cd8 cd38 t lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
topic Hematopoietic stem cell transplantation
Cytomegalovirus
Flow cytometry
Antigenemia, CD38
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000400010
work_keys_str_mv AT vaniaabadiasoareslino quantificationofcd8cd38tlymphocytesbyflowcytometrydoesnotrepresentagoodbiomarkertomonitorthereactivationofcytomegalovirusinfectionafterallogeneichematopoieticstemcelltransplantation
AT silvanamariaeloisantos quantificationofcd8cd38tlymphocytesbyflowcytometrydoesnotrepresentagoodbiomarkertomonitorthereactivationofcytomegalovirusinfectionafterallogeneichematopoieticstemcelltransplantation
AT henriquenevesdasilvabittencourt quantificationofcd8cd38tlymphocytesbyflowcytometrydoesnotrepresentagoodbiomarkertomonitorthereactivationofcytomegalovirusinfectionafterallogeneichematopoieticstemcelltransplantation
AT marialuizasilva quantificationofcd8cd38tlymphocytesbyflowcytometrydoesnotrepresentagoodbiomarkertomonitorthereactivationofcytomegalovirusinfectionafterallogeneichematopoieticstemcelltransplantation
AT tiagospizziri quantificationofcd8cd38tlymphocytesbyflowcytometrydoesnotrepresentagoodbiomarkertomonitorthereactivationofcytomegalovirusinfectionafterallogeneichematopoieticstemcelltransplantation
AT raquelbretas quantificationofcd8cd38tlymphocytesbyflowcytometrydoesnotrepresentagoodbiomarkertomonitorthereactivationofcytomegalovirusinfectionafterallogeneichematopoieticstemcelltransplantation
AT suzaneprettifigueiredoneves quantificationofcd8cd38tlymphocytesbyflowcytometrydoesnotrepresentagoodbiomarkertomonitorthereactivationofcytomegalovirusinfectionafterallogeneichematopoieticstemcelltransplantation